RxDoctor Payments Data

Leeann Rhodes, MD

Pain Medicine · Annapolis, MDNPI 1386629004

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Boston Scientific at 40.4% of the total. Reporting peaked in 2024 at $1,241 and has fallen 54.9% since, to $559 in 2025.

$3,416in general payments, 2019–2025

Across 128 payments — averaging $26.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Saluda Medical Americas, Inc.$424
  • Si-bone, Inc.$404
  • Abbott$395
  • AbbVie$211
  • Vertos Medical, Inc.$152
  • plus $450 from 10 others

What the payments were for

  • Travel & lodging$792%
  • Food & beverage$3,32497%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,416 in reported general payments places this provider in the 65th percentile of 144 pain medicine providers in Maryland.

See all pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$262,794
Medicare patients
492
Services billed
3,160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin201$1,904
Lidocaine11$1,825
Duloxetine Hcl44$1,534
Pregabalin63$1,253
Methadone Hcl38$603
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$471
Nortriptyline Hcl25$449
Oxycodone Hcl39$446
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$300
Cyclobenzaprine Hcl15$291
Morphine Sulfate15$180
Tramadol Hcl23$159
Baclofen11$148
Cephalexin13$82
Tizanidine Hcl16$62

Paid to pharmacies, not to this prescriber.

Other pain medicine in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →